期刊
GYNECOLOGIC ONCOLOGY
卷 143, 期 3, 页码 472-478出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2016.10.018
关键词
Exenteration; Uterine neoplasms; Survival; Prognosis
Objective. To determine overall survival (OS) and factors associated with OS after pelvic exenteration for uterine cancer. Methods. Women with uterine cancer who underwent exenteration (n = 1160) were identified from the 1998-2011 National Cancer Data Base. Kaplan-Meier and multivariate Cox proportional-hazards survival analyses were performed to test for associations of potential explanatory variables with OS. Analyzed confounders included age, comorbidity score, insurance status, income, distance from home to treatment center, stage, distant and nodal metastasis, tumor size, surgical margin status, exenteration type, and treatment with radiation and/or chemotherapy. Results. Among women with follow-up data (n = 652), median (IQR) OS was 63.1 (42.2-107.2) and 17.6 (14.7-23.9) months for women with node-negative versus node-positive disease, respectively. Histology (p = 1.5 x 10(-4)), grade (p = 7.9 x 10(-14)), race (p = 0.0002), lymph node status (p = 1.0 x 10(-14)), surgical node evaluation (p = 2.8 x 10(-8)), surgery for distant metastasis (p = 0.004), distant metastasis at diagnosis (p = 1.3 x 10(-10)), positive surgical margins (p = 1.6 x 10(-9)), radiotherapy (p = 0.004), and insurance status (p = 6.5 x 10(-8)) were significantly associated with differential, unadjusted Kaplan-Meier OS estimates. Exenteration type was not associated with OS (p = 0.357). By multivariate regression, increased age, positive surgical margins, nodal metastasis or unknown nodal status, higher histologic grade, and black race were associated with increased hazards for death. Conclusion. Exenteration may be curative for well-selected women with uterine cancer, particularly among women with pathologically negative lymph nodes. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据